Unraveling of Diagnosis Odyssey in A Girl with Primary Amenorrhea: A case report by Susanti, Ni Made Indri Dwi et al.
 J.Biomed.Transl.Res 
ISSN: 2503-2178 
 
 
 
 
  
 
 
 
 
Copyright©2020 by Faculty of Medicine Diponegoro University and Indonesian Medical Association, Central Java Region 
 
Case Report 
Unraveling of Diagnostic Odyssey in A Girl with Primary Amenorrhea: 
A case report 
 
 Ni Made Indri D Susanti1*, Inu Mulyantoro1, Dik Puspasari2, Nurin A Listyasari3, Sultana MH Faradz3 
 
1Department of Obstetrics and Gynecology, Faculty of Medicine Diponegoro University / 
Dr. Kariadi General Hospital, Semarang Indonesia 
2Departement of Anatomy Pathologic, Faculty of Medicine Diponegoro University/ 
Dr. Kariadi General Hospital, Semarang Indonesia 
3Center for Biomedical Research, Faculty of Medicine Diponegoro University, Semarang Indonesia 
 
Article Info 
History: 
Received: 01 Nov 2019 
Accepted: 06 Feb 2020 
Available: 30 April 2020 
Abstract 
Primary amenorrhea may result from congenital abnormalities in the development of 
the gonads, genital tract, or external genitalia or from a disturbance within the 
hypothalamic-pituitary-ovarian axis. Gonadal dysgenesis is a disorder of sex 
development in which the diagnosis is based on the histology of gonads and is the main 
cause of primary amenorrhea. Optimal protocol of management for phenotypic female 
with 46, XY gonadal dysgenesis involves prophylactic gonadectomy at diagnosis. 
Case Presentation: The patient was referred to our hospital at the age of 15 years old 
for primary amenorrhea. She was obese with no secondary sex signs. Gynecologic 
examination revealed a normal vagina and clitoris. Rectal Toucher examination 
revealed no internal genitalia structure. The laboratory data: FSH levels were above 
normal range, LH and testosterone levels were within normal range. In pelvic 
ultrasonography uterus and vaginal structure and testis were not visualized. 
Cytogenetic and AR gene analysis found a 46, XY karyotype and no pathogenic 
variants. On laparoscopy, Mullerian structure and Wolffian remnant structure were 
identified and biopsies were performed. Based on histopathological examination and 
immunohistochemical markers of the right and left gonad showed the impression of 
Malignant Mixed Germ Cell-Sex Cord Stromal Tumor. SRY gene examination was 
positive. Examination of other DSD gene analysis has not been done. A Second 
laparoscopy for gonadectomy and removal of Mullerian and Wolffian remnant 
structure were performed.  
Conclusion: Chromosomal analysis should become the first line testing in primary 
amenorrhea followed by advanced molecular test. Multidisciplinary management is 
recommended for DSD cases. 
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INTRODUCTION 
 Primary amenorrhea is the failure of menses to occur 
by age 16 years, in the presence of normal growth and 
secondary sexual characteristics or failure of menses to 
occur by age 14 in the absence of normal growth and 
secondary sexual characteristic. Primary amenorrhea is 
most common caused by gonadal dysgenesis 
(approximately 30-40%), followed by Mullerian 
agenesis, and androgen insensitivity syndrome.1  
 The term disorders of sex development (DSD) are 
defined by “congenital conditions in which development 
of chromosomal, gonadal or anatomical sex is atypical.”2 
DSD classification proposed by the multidisciplinary 
conference in Chicago 2005 are 46, XX DSD, 46, XY 
DSD and sex chromosomal DSD.2-4  
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The overall incidence rate for DSD is 1 in 5.500, genetic 
deformities during sexual differentiation is the 
predominant caused.3 DSD are commonly correlated 
with genital ambiguity, that often caused physical and 
psychological problems. Patients with XY pure gonadal 
dysgenesis, XY mixed gonadal dysgenesis and XY 
androgen insensitivity syndrome known to be DSD in 
XY phenotypic females.5  
 Presentation and distinctive measures of XY pure 
gonadal dysgenesis are presence of female external and 
internal genitalia with 46, XY karyotype.  The patients 
usually have no Turner stigmata and may present with 
uterus and oviducts and nonappearance of follicles in the 
gonadal line. The failure of gonad differentiation into 
functional testes in 46, XY pure gonadal dysgenesis 
DSD caused the reproductive tract formed into a female 
pathway.6 Mixed gonadal dysgenesis is identified in 
patients with a one sided testis (frequently intra-
abdominal), a contra-lateral gonadal line, formation of 
pertinacious Mullerian duct with differing levels of 
undermasculinization.5 The great number of patients 
diagnosed with gonadal dysgenesis have an evident 
anomaly implicating X chromosome, although 
mosaicism also have been reported with Y 
chromosomes.1 Androgen insensitivity syndrome (AIS) 
is a rare X-linked disorders due to pathogenic variants in 
the androgen receptor (AR) gene (Xq11–q12).7,8 
Molecular diagnosis was made by identification of 
pathogenic variants in the AR gene.9 
 The scarcity of 46 XY GD patients with an incidence 
rate 1 in 100.000 in which most cases caused by genetic 
disorders.10 Patients with GD conventionally have 
mutations on the testis-determining gene SRY11, and 
other genes such as WT1, DHH, NR5A1, SOX9, GATA4, 
FOG2/ZFPM2, and MAP3K1, as well as chromosomal 
adjustment including deletions of chromosome 9p and 
duplications of Xp22.12,13 After the diagnosis is 
established, immediate gonadectomy must be 
performed, because there is 30% risk of malignant 
gonadal line alterations in patients with 46, XY complete 
gonadal dysgenesis (CGD) at the age 40 years. 
Gonadoblastoma is the most common gonadal tumor in 
46, XY CGD.  Most dysgerminoma are gonadoblastoma 
associated with malignant germ cell tumors with an 
incidence of 50%-60% of cases.14 It is very important to 
be able to carry out a careful initial assesment and early 
identification, because there is a risk for malignancy 
alterations that can occur in early life and increases 
sharply with age even though the history of the origin of 
gonadoblastoma is unclear.15 Gonadal histology is the 
basis for establishing a diagnosis of  gonadal dysgenesis 
which is a disorder of sex development. Preventive 
gonadectomy at diagnosis is the most ideal management 
protocols for phenotypic females with 46, XY GD. In 
this case report we present a case of primary amenorrhea 
with gonadal dysgenesis 
 
CASE REPORTS 
 The patient was referred at the age of 15 years old for 
primary amenorrhea. She was obese (Asian criteria), 
weighing 77,7 kg for a height 166 cm (BMI 28 kg/m2). 
Her pubertal status based on Tanner scale, was A1, M1, 
P1. Gynecologic examination revealed a normal vagina 
and clitoris. Rectal Toucher examination revealed no 
internal genitalia structure was found. The laboratory 
data: FSH levels 47.15 mIU/ml (normal range: 0.57-8.77 
mIU/ml), LH levels 10.53 mIU/ml (normal range: ≤
15.97 mIU/ml), testosterone level 17.15ng/dl (normal 
range: 14.12-48,99 ng/dl). In pelvic ultrasonography 
uterus and vagina structure were not visualized and no 
testes structure were identified. Approval from the 
medical ethics committee of Faculty of Medicine 
Diponegoro University and informed consent from the 
patients and her parents prior to their participation in this 
case report were obtained. Her karyotype was 46, XY. AR 
gene analysis was no mutation. On laparoscopy, 
Mullerian structure (uterus, fallopian tubes, and gonads) 
was identified (fig. 1), a vas deferens-like structure in the 
lateral pelvic wall was found and biopsies were 
performed. Based on histopathological examination and 
immunohistochemical profile of the right and left gonad 
showed seminiferous tubules containing Leydig cells and 
no visible epithelial layer of the ductal deferens with the 
impression of Malignant Mixed Germ Cell-Sex Cord 
Stromal Tumor. Mullerian structures were not confirmed. 
Immunohistochemical markers for gonadal germ cell 
tumors are positive for PLAP and CD117. Further 
analysis of DSD genes, SRY gene alleles was found. 
Examination of other DSD gene analysis has not been 
done. The patient was consulted to the urology 
department for a second laparoscopy, gonadectomy and 
removal of Mullerian/Wolffian remnant structure were 
performed. Gonadal dysgenesis with gonadoblastoma 
and Malignant Germ Cell Tumor was confirmed. 
Figure 1. Laparoscopic of Mullerian structure.  
Left/Right streak gonad(arrow), left/right fallopian tubes 
(double arrow), uterus (up arrow). 
 
DISCUSSION 
 Performing cytogenetic investigation procedures is a 
compelling reason for every patient experiencing 
hypergonadotropic hypogonadism related with external 
and internal genitalia in female even when there is no 
clinical characteristic of Turner syndrome, but it is 
difficult to gain karyotypes. This was done considering 
the significant proportion of XY patients among those 
with GD. Current research shows there is a high 
incidence of XY patients among those with GD where 
more than one third of the specimen has a chromosome 
structure, which shows the prominence of analyzing the 
karyotype of patients with this clinical feature.16 
 The phenotype of female with a blind vaginal pouch 
and no uterus is a distinctive sign of Complete Androgen 
Insensitivity Syndrome (CAIS). The existence of testes 
with histology according to testicular differentiation, 46, 
XY karyotype, and nonappearance of Müllerian duct 
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remnants are needed to establish the diagnosis of AIS.17 
Primary amenorrhea is highly prevalent complaint that 
requires medical support during puberty. The clitoris and 
labia minora are underdeveloped in some cases.9 The 
proband referred to our clinic by reason of primary 
amenorrhea. Based on the clinical evaluation supported 
by hormonal assay and cytogenetic analysis, the patients 
were clinically diagnosis had CAIS and the AR gene 
analysis were performed. The analysis was only 
covering 8 exons of AR gene, to determine whether 
mutations were in the intron or regulatory region, it 
should proceed to a more advanced examination using 
the whole gene sequencing. Jaaskelainen (2012) 
declared that there are a large number of diverse 
mutations in the AR gene related with AIS. Missense 
mutations are the majority of mutations and most affect 
the ligand-binding domain of the AR. Exon 1 novel 
mutations values will increase if this exon is orderly 
filtered for mutations. Several cases shown where there 
were AIS characteristics in vivo and in vitro but no 
mutations in the AR coding area can be found. There has 
never been a case with mutations that occurred in the AR 
promoter region even though this could happen 
theoretically.17 Listyasari, et al (2019) reported clinical, 
imaging, hormonal, and molecular analysis among girls 
with primary amenorrhea, confirmed have CAIS. 18 The 
clinical findings of this patient with no secondary sex 
signs, and from the molecular analysis of this patient, 
however, revealed no pathogenic variants in all exon, 
and diagnostic laparoscopy identified Müllerian 
structure, consequently the diagnosis of CAIS is 
excluded. 
 In pelvic ultrasonography of the patient showed that 
uterus and vaginal structure were not visualised and no 
testis structure were identified. The facts provided by 
pelvic MRI are superior to ultrasonography in 
recognizing Mullerian structures.19  
 The majority types of tumors found in patients with 
DSD are gonadoblastoma and dysgerminoma.20 It is a 
well-established association between the Y-derived 
chromosome materials and the development of 
gonadoblastoma. It is known approximately in 15 – 20% 
cases of X/XY patients and 30% cases of patients with 
XY gonadal dysgenesis will develop gonadoblastoma.21 
In this case reports, the patient was confirmed for 
gonadoblastoma and Malignant Germ Cell Tumor. 
Gonadoblastoma described as an in-situ germ cell 
neoplasm that has potential for developing malignant 
germ cell tumors such as dysgerminoma.22,23 
Gonadoblastoma can be identified in gonadal tissue with 
undifferentiated or immature testis differentiation.4 It 
was hypothesized from scientist that several factors 
involved in the evolution of gonadoblastoma during the 
gonad differentiation process were identical to factors 
involved in the growth of dysgenetic gonads.24 At 
present there are no genes that act as oncogene and are 
involved in the development of the gonadoblastoma 
locus on the Y chromosome. Patients with sex reversal 
showing pathogenic variants in WT1 and SOX9 genes, 
9p deletions can have this tumor.25,26 
 Comprehension of DSD category, age, and level of 
individual pubertal status is needed to make an 
appropriate timing of gonadectomy that will become a 
prominent point in DSD managements. Individuals with 
46, XY GD and germ cell tumors have an incidence rate 
approximately at 25-33%.27,28 There was a strong 
recommendation to do an early gonadectomy at 
diagnosis.5 In this case, patient was 15 years old and 
based on the histopathological and immunohistochemical 
findings from the first laparoscopic biopsies showed 
malignancy. Evidence of gonadal germ cell tumors is 
confirmed by immunohistochemical marker staining 
using PLAP and CD117.29 Therefore we performed a 
second laparoscopy for gonadectomy and removal of the 
Mullerian and Wolffian structure. Gonadal dysgenesis 
with gonadoblastoma and Malignant Germ Cell Tumor 
was confirmed based on anatomic pathology result.
 Patients and their families frequently feel pressure 
after the establishment of the DSD diagnosis. 
Management collaboration between psychological care 
and counselling by psychologist is needed other than 
appropriate medical and surgical care.30 As to our DSD 
patient, a comprehensive multidisciplinary team is 
essential in order to provide the best of care for patient 
with DSD followed by genetic counseling and 
psychological support for the patient, and her family 
members. In this patient, gender assignment as female 
was made based on evaluation of gender identity and 
gender role by the multidisciplinary team in our center, 
taking into account the patient’s wish.31  
 In collaboration with the urology department, 
patient’s improvement was assessed for 3 months and 
planned to be given substitution of estrogen to promote 
her secondary sex development, to reduce risk of 
osteoporosis and cardiovascular disease. Furthermore, 
for long-term treatment, psychological care will be 
carried out. 
 
CONCLUSION 
 Chromosomal analysis should become the first line 
testing in primary amenorrhea. A comprehensive and 
multidisciplinary approach of DSD is paramount for 
clinical managements for primary amenorrhea patients. 
Genetic etiology such as mutation involving the testis-
determining gene SRY and other genes involved in sex 
determination should be elucidated through advanced 
molecular analysis such as gene panel using massive 
parallel sequencing. 
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